Emily Titus
Senior Vice President, Technical Operations @ Notch Therapeutics
q3ydj9@w8r9a5r.qdd
Sign up to see email
Known information
- Earned a Ph.D. from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto
- Used a combination of laboratory and bioinformatics approaches to define and interpret gene regulatory networks controlling embryonic stem cell fate decisions
- Was Vice President, Technology Advancement at CCRM before joining Notch Therapeutics
- Led the formation of Notch Therapeutics as part of CCRM's company incubation program
- Built cell reprogramming, genome engineering, and pluripotent stem cell differentiation programs at CCRM
About Notch Therapeutics
Notch Therapeutics is a biotechnology company that develops cellular immunotherapies for cancer treatment, utilizing a proprietary platform to engineer pluripotent stem cells into therapeutic cells.